Shelter Pharma Limited has announced a board meeting to revisit its proposal for raising funds through a rights issue of equity shares. The board will also consider raising capital via warrants or other securities, possibly convertible into equity, through preferential, rights, or other allowable methods. These fundraising steps aim to strengthen the company’s financial position, subject to necessary approvals. The company has initiated a trading window closure for designated persons around the board meeting, ensuring compliance with its insider trading policies. This move signals Shelter Pharma’s focus on strategic capital expansion to support its operations.